About this trial
The study assesses integrative medicine intervention effects on healthcare providers' quality-of-life during wartime.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Healthcare providers reporting war-related concerns affecting their quality of life
Disqualifiers
None
Trial design
Single group
Treatments tested in this trial
Integrative medicine including manual and/or mind-body treatments
Other interventionReferred HCPs are recommended a multi-modal IM program, include at least one of the following: acupuncture; manual-movement therapies (e.g., acupressure, Anthroposophic medicine touch therapies, reflexology, Qi Gong, and Feldenkrais method); and mind-body medicine (e.g., relaxation and breathing techniques).
Treatment groups
Trial outcomes
Primary outcomes
Assessing HCPs QoL-related concerns using the Measure Yourself Concerns and Wellbeing (MYCAW).
The MYCAW asks patients to list their two most significant concerns and general feeling of wellbeing (from 0, "doesn't bother me at all"; to 6, "bothers me greatly"). At post-treatment, the HCPs are asked to re-score the two original leading concerns and general well-being, followed by two open-ended questions about "Other things affecting your health"; and "What has been most important for you?" with respect to the IM treatments they had received. In the post-intervention narratives, HCPs are asked to describe the most important aspects of their treatment. HCP narratives are considered as free-text narratives, which may be qualitatively analyzed using ATLAS.Ti software for systematic coding, to identify clusters of emotional-spiritual keywords (ESKs), such as "calming", "release", "relaxation" and "disengagement".
Assessment of objective physiological changes during the intervention
Assessment of objective physiological changes during the 30-minute intervention are conducted using chest-lead electrocardiogram monitoring autonomic heart rate variability (HRV) throughout the intervention.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.